AMGEN INC

AMGN · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $184.7B · 31,500 employees
137
SEC Filings
$329.13
Close 2026-06-01
1
Transcripts
31,500
Employees

Business Summary

Amgen Inc. is a leading independent biotechnology company that discovers, develops, manufactures, and delivers innovative human therapeutics. Founded in 1980, it operates in approximately 100 countries and focuses on areas of high unmet medical need. Key products include Prolia, XGEVA, Repatha, Otezla, TEZSPIRE, TEPEZZA, KRYSTEXXA, UPLIZNA, IMDELLTRA, and MariTide, targeting cardiovascular disease, osteoporosis, inflammation, oncology, and rare diseases.

Latest Stock Quote

AMGN 2026-06-01 $329.13 O:$333.38 H:$333.83 L:$326.35 Vol:2.1M VWAP:$329.151
origin leaf: b09ded53ad4a836660acb6163fc53d36784bd7443b84f6eb8c8a1a92ee95ec2d

Next Earnings

expected 2026-08-06

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionAMGNdiscussed Cybersecurity
topic_mentionAMGNdiscussed Blockchain & Crypto
topic_mentionAMGNdiscussed Capital Expenditure
topic_mentionAMGNdiscussed Supply Chain
topic_mentionAMGNdiscussed Regulation
topic_mentionAMGNdiscussed Sovereign & Government
topic_mentionAMGNdiscussed Automotive
topic_mentionAMGNdiscussed Healthcare & Bio
metricAMGN EPSreported $5.29
metricAMGN EPSreported $21.84
outlookAMGNstated we expect accelerated sales erosion driven by increased competition, as multiple biosimilars have launched globally
outlookAMGNstated we expect accelerated sales erosion driven by increased competition, as multiple biosimilars have launched globally

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-132025-12-310000318154-26-000010EDGAR104K words
2025-02-142024-12-310000318154-25-000010EDGAR—
2024-02-142023-12-310000318154-24-000011EDGAR—
2023-02-092022-12-310000318154-23-000017EDGAR—
2022-02-162021-12-310000318154-22-000010EDGAR—
2021-02-092020-12-310000318154-21-000010EDGAR—
2020-02-122019-12-310000318154-20-000017EDGAR—
2019-02-132018-12-310000318154-19-000008EDGAR—
2018-02-132017-12-310000318154-18-000004EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-05-012026-03-310000318154-26-000057EDGAR—
2025-11-052025-09-300000318154-25-000072EDGAR38K words
2025-08-062025-06-300000318154-25-000056EDGAR—
2025-05-022025-03-310000318154-25-000020EDGAR—
2024-10-312024-09-300000318154-24-000044EDGAR—
2024-08-072024-06-300000318154-24-000035EDGAR—
2024-05-032024-03-310000318154-24-000020EDGAR—
2023-10-312023-09-300000318154-23-000064EDGAR—
2023-08-042023-06-300000318154-23-000053EDGAR—
2023-04-282023-03-310000318154-23-000029EDGAR—
2022-11-042022-09-300000318154-22-000055EDGAR—
2022-08-052022-06-300000318154-22-000041EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-05-200001193125-26-232786EDGAR—
2026-05-190000318154-26-000097EDGAR—
2026-04-300000318154-26-000054EDGAR—
2026-04-220000318154-26-000048EDGAR—
2026-02-190001193125-26-059490EDGAR17K words
2026-02-030000318154-26-000003EDGAR—
2026-01-300001193125-26-030518EDGAR—
2025-11-040000318154-25-000070EDGAR—
2025-08-050000318154-25-000054EDGAR—
2025-05-270000950170-25-077233EDGAR—

137 total filings indexed. 106 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Earnings Transcripts

Call DateQuarterTitle
— AMGN Earnings Call Transcript

Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc. ABOS — Acumen Pharmaceuticals, Inc.

Tags

cardiovascular-disease oncology osteoporosis-and-bone-health inflammation-and-immunology rare-diseases obesity-and-metabolic-disease neurology

Company Identity

CIK0000318154
TickerAMGN
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.amgen.com
Listed1983-06-17

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f3bbd287c90fbc62b3d9de8f33379c4e2d0a3dc20f85d0f3be607ed8cca693f4
parent: e0a095fad684c1334626f6c6019b8e245c366b11419f472b03c3eb4124b2bfcb
content hash: 371240a7237de33d5bb8dc56bb69f1f7a173ef9253a19ea767994cb127564605
signed: 2026-06-02T19:00:11.022Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf